IL17A and psoriasis: Recent research suggests that estrogen affects the expression of immune cells (DCs and γδT cells), chemokines (CCL5 and CXCL10), and cytokines (TNF-α, IL-23, and IL-17 family), which worsens cutaneous inflammation in psoriasis and provides new insights for developing treatment strategies (188).